CompanyGraph
At a glance
- Depends onDownstream position: depends on 18 industries, supplies 6
- ScaleLevered free cash flow is $25.77M, above the global median of $18.73M
- FinancialsAltman Z-Score 0.69: distress zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
375.83MUSDvs all stocks (USD)
Revenue (TTM)
450.45MUSDvs all stocks (USD)
Profit Margin
-4.16%Beta
1.39xvs all stocks
52-Week Change
-46.77%vs all stocks
Market Capitalization
375.83MUSDvs all stocks (USD)
Enterprise Value
643.34MUSDvs all stocks (USD)
Forward P/E
10.68xPrice to Sales (TTM)
0.8433xPrice to Book (MRQ)
0.7756xEnterprise to Revenue
1.43xEnterprise to EBITDA
7.48xGross Margin
55.20%Profit Margin
-4.16%Operating Margin
1.68%Return on Assets (TTM)
1.99%Return on Equity (TTM)
-3.78%Revenue (TTM)
450.45MUSDvs all stocks (USD)
Revenue per Share (TTM)
3.36USDUpdated Sep 26, 2026Quarterly Revenue Growth
6.40%Gross Profit (TTM)
251.10MUSDvs all stocks (USD)
EBITDA (TTM)
79.91MUSDvs all stocks (USD)
Net Income (TTM)
-18.76MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
6.41%Operating Cash Flow (TTM)
34.18MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
25.77MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Sep 26, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Minority Interest (Equity)
6.12MUSDFY2026 · Mar 31, 2026Revenue
443.78MUSDFY2026 · Mar 31, 2026Cost of Goods Sold
197.35MUSDFY2026 · Mar 31, 2026Gross Profit
246.42MUSDFY2026 · Mar 31, 2026Operating Income
19.58MUSDvs all stocks (USD)
Pre-tax Income
-11.26MUSDFY2026 · Mar 31, 2026Income Tax Expense
8.69MUSDFY2026 · Mar 31, 2026Net Income
-19.94MUSDFY2026 · Mar 31, 2026EBIT
16.27MUSDFY2026 · Mar 31, 2026EBITDA (Income Statement)
76.55MUSDFY2026 · Mar 31, 2026Research & Development
18.36MUSDFY2026 · Mar 31, 2026Selling, General & Administrative
208.49MUSDFY2026 · Mar 31, 2026Non-operating Interest Income
780.00KUSDFY2026 · Mar 31, 2026Non-operating Interest Expense
27.53MUSDFY2026 · Mar 31, 2026EPS (Basic)
-0.1500USDFY2026 · Mar 31, 2026EPS (Diluted)
-0.1500USDFY2026 · Mar 31, 2026Basic Shares Outstanding
133.76MSharesFY2026 · Mar 31, 2026Diluted Shares Outstanding
133.76MSharesFY2026 · Mar 31, 2026Net Income from Continuing Operations
-20.55MUSDFY2026 · Mar 31, 2026Minority Interests (P&L)
-608.00KUSDFY2026 · Mar 31, 2026Preferred Stock Dividends
0.00USDFY2026 · Mar 31, 2026Operating Cash Flow
16.73MUSDFY2026 · Mar 31, 2026Free Cash Flow
16.59MUSDDerived from operating cash flow minus capital expenditure. This filing charges 60.28M of depreciation against 140K of capital expenditure, and its own free-cash-flow line reads -9.69M.FY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
40.82MUSDFY2026 · Mar 31, 2026Income Tax Paid
7.25MUSDFY2026 · Mar 31, 2026Interest Paid
24.49MUSDFY2026 · Mar 31, 2026Starting Profit (CF Statement)
-20.55MUSDFY2026 · Mar 31, 2026Depreciation & Amortization
60.28MUSDFY2026 · Mar 31, 2026Deferred Taxes (CF)
-1.74MUSDFY2026 · Mar 31, 2026Stock-based Compensation
7.54MUSDFY2026 · Mar 31, 2026Other Non-cash Items
2.27MUSDFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
-21.23MUSDFY2026 · Mar 31, 2026Change in Accounts Payable (CF)
5.23MUSDFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
-15.07MUSDFY2026 · Mar 31, 2026Capital Expenditures
140.00KUSDFY2026 · Mar 31, 2026Net Acquisitions
55.00KUSDFY2026 · Mar 31, 2026Other Investing Activity
207.00KUSDFY2026 · Mar 31, 2026Net Investing Cash Flow
402.00KUSDFY2026 · Mar 31, 2026Long-term Debt Issuance
0.00USDFY2026 · Mar 31, 2026Long-term Debt Payments
-5.60MUSDFY2026 · Mar 31, 2026Net Short-term Debt Issuance
5.72MUSDFY2026 · Mar 31, 2026Common Stock Repurchase
0.00USDFY2026 · Mar 31, 2026Common Dividends Paid
0.00USDFY2026 · Mar 31, 2026Net Financing Cash Flow
112.00KUSDFY2026 · Mar 31, 2026Shares Outstanding
134.23MSharesUpdated Sep 26, 2026Float Shares
124.01MSharesUpdated Sep 26, 2026Shares Short
14.43MSharesUpdated Sep 26, 2026Short Ratio
10.03daysvs all stocks
Short % of Shares Outstanding
11.39%vs all stocks
% Held by Insiders
6.29%vs all stocks
% Held by Institutions
87.45%vs all stocks
Total Cash (MRQ)
32.82MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.2480USDUpdated Sep 26, 2026Total Debt (MRQ)
295.61MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.6047xCurrent Ratio (MRQ)
1.10xBook Value per Share (MRQ)
3.65USDUpdated Sep 26, 2026Total Assets
955.57MUSDvs all stocks (USD)
Total Current Assets
179.18MUSDFY2026 · Mar 31, 2026Total Liabilities
473.95MUSDFY2026 · Mar 31, 2026Total Non-current Assets
776.38MUSDFY2026 · Mar 31, 2026Total Non-current Liabilities
316.00MUSDFY2026 · Mar 31, 2026Total Current Liabilities
157.95MUSDFY2026 · Mar 31, 2026Cash & Cash Equivalents
36.50MUSDFY2026 · Mar 31, 2026Accounts Receivable
93.82MUSDFY2026 · Mar 31, 2026Inventory
22.45MUSDFY2026 · Mar 31, 2026Accounts Payable
46.35MUSDFY2026 · Mar 31, 2026Short-term Debt
53.74MUSDFY2026 · Mar 31, 2026Deferred Revenue
20.16MUSDFY2026 · Mar 31, 2026Other Current Liabilities
3.32MUSDFY2026 · Mar 31, 2026Long-term Debt
243.17MUSDFY2026 · Mar 31, 2026Other Non-current Liabilities
3.09MUSDFY2026 · Mar 31, 2026Common Stock (Book)
1.34MUSDFY2026 · Mar 31, 2026Retained Earnings
-226.34MUSDFY2026 · Mar 31, 2026Total Shareholders' Equity
481.62MUSDvs all stocks (USD)
Treasury Stock
11.52MUSDFY2026 · Mar 31, 202652-Week Low
2.78USDUpdated Sep 26, 202652-Week High
5.88USDUpdated Sep 26, 202652-Week Change
-46.77%vs all stocks
Beta
1.39xvs all stocks
50-Day MA
3.36USDUpdated Sep 26, 2026200-Day MA
3.87USDUpdated Sep 26, 2026Avg 10-Day Volume
1.37MSharesUpdated Sep 26, 2026Avg 30-Day Volume
1.49MSharesUpdated Sep 26, 2026Diluted EPS (TTM)
-0.1300USDUpdated Sep 26, 2026Other Income / Expense
-4.09MUSDFY2026 · Mar 31, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.55Profit Margin: -0.04
Financial Health
Altman Z-Score 0.69: distress zoneCritical
Altman Z-Score: 0.69
Supply Chain
Downstream position: depends on 18 industries, supplies 6Notable
Outgoing: 6.00Incoming: 18.00
High connectivity hub: 24 industry connectionsNotable
Total Connections: 24.00
Scale
Levered free cash flow is $25.77M, above the global median of $18.73MNotable
Levered free cash flow (USD): 25,774,750Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Bakkt Holdings, Inc.
Tier 1FlowRecurring-Revenue Lock-InInterfaceRisk
Lesaka Technologies, Inc.
Tier 1FlowRecurring-Revenue Lock-InInterfaceProduction
Rimini Street Inc.
Tier 1FlowRecurring-Revenue Lock-InSenseMakingInterface
Network People Services Technologies Ltd.
Tier 1FlowRecurring-Revenue Lock-InInterfaceProduction
Yeahka Ltd.
Tier 1FlowRecurring-Revenue Lock-InInterfaceRisk
Optima Health plc
Tier 1FlowRecurring-Revenue Lock-InInterfaceSenseMaking
NHN KCP Corp.
Tier 1FlowRecurring-Revenue Lock-InRiskInterface
63 Moons Technologies Ltd.
Tier 1FlowRecurring-Revenue Lock-InInterfaceProduction
Evolent Health Inc.
Tier 1FlowRecurring-Revenue Lock-InProductionInterface
International Money Express Inc.
Tier 1FlowRecurring-Revenue Lock-InRiskInterface
Companies that share active interpretations — structural patterns currently present in both stocks.
Anbio Biotechnology Limited
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Md Entertainment Tbk
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Beijing Xiaocheng Technology Co. Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated